Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Axcel VI and Currentum in connection with the acquisitions of Gullikssons El, Elkalkyl och Elprojektering and Reglerab
Mandate

Vinge advises Axcel VI and Currentum in connection with the acquisitions of Gullikssons El, Elkalkyl och Elprojektering and Reglerab

September 13, 2022 Employment and Benefits M&A Banking and Finance Real Estate and Construction

Vinge advises Axcel VI and the Currentum Group in connection with the acquisitions of J. Gullikssons El Aktiebolag, Elkalkyl och Elprojektering i Sverige AB and Reglerab AB.

The companies provide services in planning, installation and service in the electrical and construction sectors and are based in Stockholm and Mälardalen. Together, the companies have a turnover of approximately SEK 155 million and approximately 100 employees. Following the acquisitions, Currentum is expected to have a turnover of approximately SEK 3 billion and will engage just over 1,000 employees.

Vinge’s team consisted of partner Christina Kokko together with Carl Fredrik Wachtmeister, Linnea Petersson and Philip Moré (M&A), Isak Willborg (Construction), Sara Strandberg (Employment), Calle Tengwall Pagels (Financing), Frida Ställborn (Real Estate) and Anna Ekdahl Roos (project assistant).

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025